Skip to main content

PHYTOMED AG offers further training on the medical use of cannabis

PHYTOMED AG is a long-standing expert in the production of herbal active ingredients and a provider of an extensive training and further education program for medical professionals. Since 2023, it has been offering further training for doctors and pharmacists on “cannabinoids in medicine”. The current topic is “Pharmacological properties of cannabinoids and their areas of application in medicine” with the lecturer Dr. med. Claude Vaney – a renowned neurologist and vice president of the Swiss Multiple Sclerosis Society. Dr. Vaney is on the board of Parkinson.ch and is one of the experts at the SGCM – Swiss Society for Cannabis in Medicine. Recommend this training to your doctor – it will definitely take place!

Pharmacological properties of cannabinoids and their areas of application in medicine

Thursday, August 17, 2023 3:00 p.m. – 5:15 p.m

(Price CHF 75.-)

HYBRID (Online via ZOOM or on site at PHYTOMED AG, 3415 Hasle b. Burgdorf)

Lecturer
Dr.
med. Claude Vaney Neurologist FMH, former Medical Director (Berner Klinik Montana), Vice President of the Swiss MS Society (SMSG), President of the Swiss Society for Cannabis in Medicine (SGCM)

Target audience
Doctors from different disciplines and pharmacists – no previous knowledge required.

Those interested can register here and receive further information.

The aim of the training is to provide participants with knowledge about the pharmacological properties of cannabinoids, the differences between THC and CBD, the most common indications for medical use, the side effects and the legal regulations in connection with the prescription of cannabinoids. The training offers doctors and pharmacists a valuable opportunity to expand their knowledge about the medical use of cannabinoids and to use them responsibly in practice. PHYTOMED AG is a patient supporter and supports MEDCAN with a company membership.

MEDCAN calls on doctors and medical institutions to increase their support for the prescription of cannabis in medicine and to promote training in this area. Numerous studies demonstrate the medical benefits of cannabis, and it is time to put this knowledge into practice. Through comprehensive information and training, chronically ill people can receive an alternative treatment option to conventional medications. MEDCAN has extensive expertise and is willing to share it with others.

If it is important to you that doctors are better informed about prescribing cannabis in the future, make your medical professionals aware of this training opportunity. 

Help us ensure that cannabis finds its rightful place in medicine donation or membership